Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04074434 · ClinicalTrials.gov registry record
Study Watch Atrial Fibrillation (AF) Detection Investigation
A clinical trial of Atrial Fibrillation, sponsored by Verily Life Sciences.
- Completed
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT04074434 is a study of Atrial Fibrillation that has completed, run by Verily Life Sciences. The registered enrollment target is 160 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04074434, a study of Atrial Fibrillation, has completed, sponsored by Verily Life Sciences.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-randomized study to refine the Study Watch's algorithm for AF detection within both persistent and paroxysmal AF subjects. The study will also collect data from an FDA-cleared wearable ECG sensor.
Conditions Studied
Interventions
- DEVICE Study Watch
Study Locations (1)
California
- San Diego Cardiac Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2018-11-12 |
| Est. Completion | 2019-07-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04074434
The ClinicalTrials.gov registry entry for NCT04074434 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The listed sponsor is Verily Life Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Study Watch is the first listed.
NCT04074434 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04074434 about?
NCT04074434 is a clinical study titled "Study Watch Atrial Fibrillation (AF) Detection Investigation". This is a prospective, non-randomized study to refine the Study Watch's algorithm for AF detection within both persistent and paroxysmal AF subjects. The study will also collect data from an FDA-cleared wearable ECG sensor.
What is the current status of trial NCT04074434?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2018-11-12. Estimated completion is 2019-07-22.
What conditions does trial NCT04074434 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT04074434?
The interventions under investigation include: Study Watch (DEVICE).
Who is sponsoring clinical trial NCT04074434?
This trial is sponsored by Verily Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04074434 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.